Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.99 USD
−62.72 M USD
21.74 M USD
8.25 M
About Prenetics Global Limited
Sector
Industry
CEO
Sheng Wu Yeung
Website
Headquarters
Hong Kong
Founded
2014
FIGI
BBG0131XQ4K9
Prenetics Global Limited is a health sciences company, which engages in the provision of early detection, prevention, and treatment of cancer. The firm offers products and services under the brands of CircleDNA, Insighta, ACT Genomics, IM8, and Europa. IM8, a health and wellness brand which focuses on consumer health products. Europa, a U.S. sports distribution company. Insighta, a venture which focuses on the development of early cancer detection technologies. It also focuses on its CircleDNA and ACT Genomics business units. The CircleDNA business unit uses next-generation sequencing (NGS) technology for consumer deoxyribonucleic acid (DNA) test. The ACT Genomics business unit is involved in genomic profiling of solid tumors. It has a presence in the United States. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PRE is 5.65 USD — it has increased by 3.09% in the past 24 hours. Watch Prenetics Global Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Prenetics Global Limited stocks are traded under the ticker PRE.
PRE stock has risen by 3.77% compared to the previous week, the month change is a 28.00% rise, over the last year Prenetics Global Limited has showed a 10.87% increase.
We've gathered analysts' opinions on Prenetics Global Limited future price: according to them, PRE price has a max estimate of 9.00 USD and a min estimate of 9.00 USD. Watch PRE chart and read a more detailed Prenetics Global Limited stock forecast: see what analysts think of Prenetics Global Limited and suggest that you do with its stocks.
PRE stock is 4.35% volatile and has beta coefficient of 1.62. Track Prenetics Global Limited stock price on the chart and check out the list of the most volatile stocks — is Prenetics Global Limited there?
Today Prenetics Global Limited has the market capitalization of 68.97 M, it has increased by 11.06% over the last week.
Yes, you can track Prenetics Global Limited financials in yearly and quarterly reports right on TradingView.
Prenetics Global Limited is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
PRE earnings for the last quarter are −0.84 USD per share, whereas the estimation was −0.86 USD resulting in a 2.33% surprise. The estimated earnings for the next quarter are −0.72 USD per share. See more details about Prenetics Global Limited earnings.
Prenetics Global Limited revenue for the last quarter amounts to 7.78 M USD, despite the estimated figure of 9.20 M USD. In the next quarter, revenue is expected to reach 12.40 M USD.
PRE net income for the last quarter is −10.67 M USD, while the quarter before that showed −10.72 M USD of net income which accounts for 0.46% change. Track more Prenetics Global Limited financial stats to get the full picture.
No, PRE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2024, the company has 324.00 employees. See our rating of the largest employees — is Prenetics Global Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Prenetics Global Limited EBITDA is −36.27 M USD, and current EBITDA margin is −205.67%. See more stats in Prenetics Global Limited financial statements.
Like other stocks, PRE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Prenetics Global Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Prenetics Global Limited technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Prenetics Global Limited stock shows the neutral signal. See more of Prenetics Global Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.